APT Pharma raises $22M for transplant-rejection drug
See our story on this Burlingame, Calif., specialty pharma in today’s daily briefing at VentureBeat Life Sciences.
Next Story: AzoogleAds buys search engine marketing co., Bazaar Advertising
Previous Story: BT invests in WiFi community start-up, FON
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.